BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Memorial Sloan-Kettering Cancer Center CEO Settles Embarrassing Lawsuit


9/4/2012 7:44:33 AM

In a bid to end a highly embarrassing episode, the Sloan-Kettering Cancer Center ceo and a University of Pennsylvania cancer research institute have settled a lawsuit that involved sensational charges of allegedly unscrupulous behavior and underhanded dealings centered on cutting-edge research. The terms are being kept confidential, but a licensing arrangement has been inked between the UPenn institute and a small drugmaker co-founded by the Sloan-Kettering ceo. Here is the background: Late last year, the Abramson Family Cancer Research Institute at UPenn filed a lawsuit against Craig Thompson, who joined its facility as scientific director in 1999 and undertook various research projects. But rather than honor an agreement that any discoveries belonged to the Institute, the lawsuit claimed Thompson chose to “abscond with the fruits of the Abramson largesse,” which at the time purportedly amounted to $110 million.

Read at Pharmalot

Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES